📰 Merck Sharp News
Page 81 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
February 12, 2022
Invasive aspergillosis (IA) – Market outlook, Epidemiology, Market Forecast and Competitive Landscape Report – 2020 To 2030
February 10, 2022
The addition of neoadjuvant pembrolizumab to chemotherapy reduced triple negative breast cancer recurrence by more than a third, trial results suggested.
February 10, 2022
The trial, named KEYNOTE-522, is the first phase III trial to demonstrate the benefit of adding immunotherapy to chemotherapy before patients receive
February 10, 2022
The Ministry of Health has distributed 60,000 courses of COVID antiviral medicine Molnupiravir to the regions of Ukraine. — Ukrinform.
February 9, 2022
Blepharitis – Market Insight, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
February 9, 2022
Blepharitis – Market Insight, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
February 9, 2022
Alicestine October looks at how MPs have dealt with oral submissions on the Bill in Parliament so far and assesses what this means for the Bill going forward.
February 9, 2022
Around 15 of all breast cancers (more than 8,000 cases per year in the UK) are triple negative breast cancer.
February 9, 2022
Hepatitis D (HDV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030
February 9, 2022
Hepatitis D (HDV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030